Highlights in nonhymenoptera anaphylaxis

Current Opinion in Allergy and Clinical Immunology

Volumn 8, Issue 4, 2008, Pages 348-353

  Scherer, Kathrin ^a   Ballmer Weber, Barbara K ^b   Bircher, Andreas J ^a  

^a Allergy Unit   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anaphylaxis; Drug allergy; Food allergy; Monoclonal antibody

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; CETUXIMAB; DACLIZUMAB; DICLOFENAC; FOOD ALLERGEN; GEMTUZUMAB OZOGAMICIN; HYDROCORTISONE; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN E ANTIBODY; INFLIXIMAB; INOTROPIC AGENT; LIPID TRANSFER PROTEIN; MONOCLONAL ANTIBODY; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PENICILLIN G; PHOLCODINE; POLYSORBATE 80; PREDNISONE; RITUXIMAB; SUXAMETHONIUM; TOSITUMOMAB; TRASTUZUMAB; ALLERGEN; BETA LACTAM;

ACUTE GRANULOCYTIC LEUKEMIA; ALCOHOL INTOXICATION; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; BASOPHIL DEGRANULATION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COLORECTAL CARCINOMA; COMMON COLD; COMORBIDITY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; EXERCISE; FATALITY; FOOD ALLERGY; HUMAN; HYMENOPTERA; IMMUNE RESPONSE; IMMUNOGENICITY; INCIDENCE; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAST CELL; MENSTRUATION; NONHODGKIN LYMPHOMA; NONHUMAN; NUT; PATHOPHYSIOLOGY; PEANUT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOALLERGOSORBENT TEST; REVIEW; SENSITIZATION; STRESS; SYSTEMIC MASTOCYTOSIS; URTICARIA; URTICARIA PIGMENTOSA; WHEAT; ADULT; BASOPHIL; CHEMICALLY INDUCED DISORDER; DEGRANULATION; IMMUNOLOGY; METABOLISM; PRESCHOOL CHILD;

ADULT; ALLERGENS; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BASOPHILS; BETA-LACTAMS; CELL DEGRANULATION; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FOOD HYPERSENSITIVITY; HUMANS; INCIDENCE; NEUROMUSCULAR BLOCKING AGENTS; NUTS;

EID: 66149099717     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32830638df     Document Type: Review

References (49)

1. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-824.
2. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-836.
3. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97:39-43.
4. Brown SGA. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 2006; 18:155-169.
5. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98:252-257.
6. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7:337-341.
7. Przybilla B, Ring J, Rueff F. Anaphylaxis: clinical manifestations and diagnosis. Hautarzt 2007; 58:1025-1031.
8. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 (Pt 1):287-291.
9. Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007; 103:700-709.
10. Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007; 47:109-117.
11. Du Toit G. Food-dependent exercise-induced anaphylaxis in childhood. Pediatr Allergy Immunol 2007; 18:455-463.
12. Morita E, Matsuo H, Mihara S, et al. Fast omega-gliadin is a major allergen in wheat-dependent exercise-induced anaphylaxis. J Dermatol Sci 2003; 33:99-104.
13. Matsuo H, Morita E, Tatham AS, et al. Identification of the IgE-binding epitope in omega-5 gliadin, a major allergen in wheat-dependent exercise-induced anaphylaxis. J Biol Chem 2004; 279:12135-12140.
14. Fujii H, Kambe N, Fujisawa A, et al. Food-dependent exercise-induced anaphylaxis induced by low dose aspirin therapy. Allergol Int 2008; 57:97-98.
15. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63:226-232.
16. Brown SGA. The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 2007; 27:165-175.
17. Gupta R, Sheikh A, Strachan D, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ Clin Res 2003; 327:1142-1143.
18. Poulos LM, Waters AM, Correll PK, et al. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120:878-884.
19. Ross MP, Ferguson M, Street D, et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 2008; 121:166-171.
20. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clinical Immunol 2007; 119:1018-1019.
21. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:101 6-1018.
22. Hefle SL, Furlong TJ, Niemann L, et al. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J Allergy Clin Immunol 2007; 120:171 -176.
23. Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, et al. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol 2006; 118:481-488.
24. Reuter A, Lidholm J, Andersson K, et al. A critical assessment of allergen component-based in vitro diagnosis in cherry allergy across Europe. Clin Exp Allergy 2006; 36:815-823.
25. Matsuo H, Dahlstrom J, Tanaka A, et al. Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergy 2008; 63:233-236.
26. Beyer K, Grishina G, Bardina L, et al. Identification of an 11S globulin as a major hazelnut food allergen in hazelnut-induced systemic reactions. J Allergy Clin Immunol 2002; 110:517-523.
27. Antunez C, Fernandez T, Blanca-Lopez N, et al. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Allergy 2006; 61:940-946.
28. Berges-Gimeno MP, Martin-Lazaro J. Allergic reactions to nonsteroidal antiinflammatory drugs: is newer better? Curr Allergy Asthma Rep 2007; 7:35-40.
29. Naisbitt DJ, Sanderson LS, Meng X, et al. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett 2007; 168:45-50.
30. Malbran A, Yeyati E, Rey GL, Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 2007; 147:99-105.
31. Cheifetz A, Mayer L Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med 2005; 72:250-256.
32. Cox L, Platts-MillsTA, Finegold I, et al. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol 2007; 120:1373-1377.
33. Leonard PA, Woodside KJ, Gugliuzza KK, et al. Safe administration of a humanized murine antibody after anaphylaxis to a chimeric murine antibody. Transplantation 2002; 74:1697-1700.
34. Klastersky J. Adverse effects of the humanized antibodies used as cancer therapeutics. Curr Opin Oncol 2006; 18:316-320.
35. Raeder RH, Badylak SF, Sheehan C, et al. Natural antigalactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol 2002; 10:15-24.
36. Bross PF, Beitz J, Chen G, et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res 2001; 7:1490-1496.
37. Jankowitz R, Joyce J, Jacobs SA. Anaphylaxis after administration of ibritu - momab tiuxetan for follicular nonhodgkin lymphoma. Clin Nucl Med 2008; 33:94-96.
38. Price KS, Hamilton RG. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc 2007; 28:313-319.
39. Lieberman P. The unusual suspects: a surprise regarding reactions to omalizumab. Allergy Asthma Proc 2007; 28:259-261.
40. Limb SL, Starke PR, Lee CE, Chowdhury BA. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol 2007; 120:1378-1381.
41. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348:601 -608.
42. Farrell RJ, Alsahli M, Jeen YT, et al. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology 2003; 124:917-924.
43. Augustsson J, Eksborg S, Ernestam S, et al. Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66:1462-1466.
44. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983; 306:262-264.
45. Florvaag E, Johansson SG, Oman H, et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005; 49:437-444.
46. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87:549-558.
47. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99:536-545.
48. Florvaag E, Johansson SG, Oman H, et al. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. Allergy 2006; 61:49-55.
49. Harboe T, Johansson SG, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007; 62:1445-1450.